Add to ORKGIntroduction: Percutaneous closure of patent foramen ovale (PFO) has become a widely used procedure in patients with suspected paradoxical embolism. Despite being generally safe and effective, the minimally invasive intervention has been associated with several serious complications such as air embolism, cardiac perforation
Stroke is a devastating event for patients and their families. Paradoxical embolism through a patent...
AIMS: To evaluate the very long-term risk of recurrent thromboembolic events in patients treated by ...
Patent foramen ovale (PFO) is a common abnormality affecting between 20% and 34% of the adult popula...
Proof that percutaneous closure of the patent foramen ovale (PFO) is superior to medical treatment i...
Patent foramen ovale (PFO) is a very common congenital heart disease, affecting 20-30% of general po...
OBJECTIVE: To report our data on selected patients with previous paradoxical embolism who underwent ...
Stroke is a devastating event for patients and their families. Paradoxical embolism through a patent...
OBJECTIVES: This multi-centre study reports safety and efficacy of percutaneous patent foramen ovale...
Non-surgical closure of the patent foramen ovale (PFO) has been possible for 40 years and proved saf...
OBJECTIVES: This multi-centre study reports safety and efficacy of percutaneous patent foramen ovale...
BACKGROUND: Transcatheter closure of patent foramen ovale (PFO) has rapidly evolved as the preferred...
BACKGROUND: Transcatheter closure of patent foramen ovale (PFO) has rapidly evolved as the preferred...
ABSTRACT The presence of patent foramen ovale (PFO) was found to be associated with a number of med...
Background: Observational studies have favored percutaneous patent foramen ovale (PFO) closure over ...
Background: Percutaneous transcatheter closure has been proposed as an alternative to surgical closu...
Stroke is a devastating event for patients and their families. Paradoxical embolism through a patent...
AIMS: To evaluate the very long-term risk of recurrent thromboembolic events in patients treated by ...
Patent foramen ovale (PFO) is a common abnormality affecting between 20% and 34% of the adult popula...
Proof that percutaneous closure of the patent foramen ovale (PFO) is superior to medical treatment i...
Patent foramen ovale (PFO) is a very common congenital heart disease, affecting 20-30% of general po...
OBJECTIVE: To report our data on selected patients with previous paradoxical embolism who underwent ...
Stroke is a devastating event for patients and their families. Paradoxical embolism through a patent...
OBJECTIVES: This multi-centre study reports safety and efficacy of percutaneous patent foramen ovale...
Non-surgical closure of the patent foramen ovale (PFO) has been possible for 40 years and proved saf...
OBJECTIVES: This multi-centre study reports safety and efficacy of percutaneous patent foramen ovale...
BACKGROUND: Transcatheter closure of patent foramen ovale (PFO) has rapidly evolved as the preferred...
BACKGROUND: Transcatheter closure of patent foramen ovale (PFO) has rapidly evolved as the preferred...
ABSTRACT The presence of patent foramen ovale (PFO) was found to be associated with a number of med...
Background: Observational studies have favored percutaneous patent foramen ovale (PFO) closure over ...
Background: Percutaneous transcatheter closure has been proposed as an alternative to surgical closu...
Stroke is a devastating event for patients and their families. Paradoxical embolism through a patent...
AIMS: To evaluate the very long-term risk of recurrent thromboembolic events in patients treated by ...
Patent foramen ovale (PFO) is a common abnormality affecting between 20% and 34% of the adult popula...